A detailed history of Vanguard Group Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Vanguard Group Inc holds 18,175,271 shares of EXAS stock, worth $1.26 Billion. This represents 0.02% of its overall portfolio holdings.

Number of Shares
18,175,271
Previous 17,740,092 2.45%
Holding current value
$1.26 Billion
Previous $1.23 Billion 37.32%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$41.33 - $74.26 $18 Million - $32.3 Million
435,179 Added 2.45%
18,175,271 $768 Million
Q1 2024

May 10, 2024

BUY
$56.27 - $73.77 $10.1 Million - $13.3 Million
180,341 Added 1.03%
17,740,092 $1.23 Billion
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $6.8 Million - $8.71 Million
115,058 Added 0.66%
17,559,751 $1.3 Billion
Q3 2023

Nov 14, 2023

SELL
$65.94 - $99.04 $7.89 Million - $11.8 Million
-119,581 Reduced 0.68%
17,444,693 $1.19 Billion
Q2 2023

Aug 14, 2023

BUY
$62.68 - $95.05 $10.8 Million - $16.3 Million
171,986 Added 0.99%
17,564,274 $1.65 Billion
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $6.6 Million - $9.9 Million
139,823 Added 0.81%
17,392,288 $1.18 Billion
Q4 2022

Feb 10, 2023

BUY
$30.35 - $53.15 $17.5 Million - $30.6 Million
575,854 Added 3.45%
17,252,465 $854 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $22.3 Million - $34.5 Million
698,740 Added 4.37%
16,676,611 $542 Million
Q2 2022

Aug 12, 2022

BUY
$35.61 - $76.23 $12 Million - $25.6 Million
335,877 Added 2.15%
15,977,871 $629 Million
Q1 2022

May 13, 2022

BUY
$57.56 - $82.54 $12.1 Million - $17.4 Million
210,260 Added 1.36%
15,641,994 $1.09 Billion
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $4.69 Million - $6.51 Million
64,700 Added 0.42%
15,431,734 $1.2 Billion
Q3 2021

Nov 12, 2021

SELL
$90.24 - $124.05 $3.93 Million - $5.4 Million
-43,521 Reduced 0.28%
15,367,034 $1.47 Billion
Q2 2021

Aug 13, 2021

BUY
$93.66 - $139.27 $1.44 Billion - $2.15 Billion
15,410,555 New
15,410,555 $1.92 Billion

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.